The Identification of a Calmodulin-Binding Domain within the Cytoplasmic Tail of Angiotensin-Converting Enzyme-2

被引:24
|
作者
Lai, Zon W. [1 ]
Lew, Rebecca A. [1 ]
Yarski, Michael A. [3 ]
Mu, Fi-Tjen [2 ]
Andrews, Robert K. [2 ]
Smith, A. Ian [1 ]
机构
[1] Monash Univ, Dept Biochem & Mol Biol, Peptide Biol Lab, Clayton, Vic 3800, Australia
[2] Monash Univ, Cardiovasc Biol Lab, Dept Immunol Alfred Med Res & Educ Precinct, Clayton, Vic 3800, Australia
[3] Baker Heart Res Inst, Epigenet Human Hlth & Dis Lab, Melbourne, Vic 3004, Australia
关键词
ANGIOTENSIN-CONVERTING-ENZYME-2; ACE2; CALCIUM-CHANNELS; GLYCOPROTEIN-VI; UP-REGULATION; CARBOXYPEPTIDASE; HOMOLOG; CELLS; RECOGNITION; EXPRESSION; LIVER;
D O I
10.1210/en.2008-1274
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Angiotensin-converting enzyme (ACE)-2 is a homolog of the well-characterized plasma membrane-bound angiotensin-converting enzyme. ACE2 is thought to play a critical role in regulating heart function, and in 2003, ACE2 was identified as a functional receptor for severe acute respiratory syndrome coronavirus. We have recently shown that like ACE, ACE2 undergoes ectodomain shedding and that this shedding event is up-regulated by phorbol esters. In the present study, we used gel shift assays to demonstrate that calmodulin, an intracellular calcium-binding protein implicated in the regulation of other ectodomain shedding events, binds a 16-amino acid synthetic peptide corresponding to residues 762-777 within the cytoplasmic domain of human ACE2, forming a calcium-dependent calmodulin-peptide complex. Furthermore, we have demonstrated that ACE2 expressed in Chinese hamster ovary cells specifically binds to glutathione-S-transferase-calmodulin, but not glutathione-S-transferase alone, in pull-down assays using cell lysates. Finally, to investigate whether calmodulin has any effect on ACE2 ectodomain shedding in cells that endogenously express the enzyme, cells from a human liver cell line (Huh-7) expressing ACE2 were incubated with calmodulin-specific inhibitors, trifluoperazine and calmidazolium. Both trifluoperazine (25 mu mol/liter) and calmidazolium, (25 mu mol/liter) significantly increased the release of ACE2 into the medium (44.1 +/- 10.8%, P < 0.05, Student's t test; unpaired, two-tailed, and 51.1 +/- 7.4% P < 0.05, one-way ANOVA, respectively;), as analyzed by an ACE2-specific quenched fluorescence substrate assay. We also show that the calmodulin-specific inhibitor-stimulated shedding of ACE2 is independent from phorbol ester-induced shedding. In summary, we have demonstrated that calmodulin is able to bind ACE2 and suggest that the ACE2 ectodomain shedding and/or sheddase(s) activation regulated by calmodulin is independent from the phorbol ester-induced shedding. (Endocrinology 150: 2376-2381, 2009)
引用
收藏
页码:2376 / 2381
页数:6
相关论文
共 50 条
  • [31] CCAAT/enhancer-binding protein β overexpression alleviates myocardial remodelling by regulating angiotensin-converting enzyme-2 expression in diabetes
    Tie, Yuanyuan
    Zhai, Chungang
    Zhang, Ya
    Qin, Xiaoteng
    Yu, Fangpu
    Li, Hongxuan
    Shan, MeiRong
    Zhang, Cheng
    JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2018, 22 (03) : 1475 - 1488
  • [32] Calcitriol regulates angiotensin-converting enzyme and angiotensin converting-enzyme 2 in diabetic kidney disease
    Lin, Mei
    Gao, Ping
    Zhao, Tianya
    He, Lei
    Li, Mengshi
    Li, Yaoyao
    Shui, Hua
    Wu, Xiaoyan
    MOLECULAR BIOLOGY REPORTS, 2016, 43 (05) : 397 - 406
  • [33] Overexpression of catalase prevents hypertension and tubulointerstitial fibrosis and normalization of renal angiotensin-converting enzyme-2 expression in Akita mice
    Shi, Yixuan
    Lo, Chao-Sheng
    Chenier, Isabelle
    Maachi, Hasna
    Filep, Janos G.
    Ingelfinger, Julie R.
    Zhang, Shao-Ling
    Chan, John S. D.
    AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY, 2013, 304 (11) : F1335 - F1346
  • [34] Effects of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers on Angiotensin-Converting Enzyme 2 Levels: A Comprehensive Analysis Based on Animal Studies
    Kriszta, Gabor
    Kriszta, Zsofia
    Vancsa, Szilard
    Hegyi, Peter Jeno
    Frim, Levente
    Eross, Balint
    Hegyi, Peter
    Petho, Gabor
    Pinter, Erika
    FRONTIERS IN PHARMACOLOGY, 2021, 12
  • [35] Identification of critical active-site residues in angiotensin-converting enzyme-2 (ACE2) by site-directed mutagenesis
    Guy, JL
    Jackson, RM
    Jensen, HA
    Hooper, NM
    Turner, AJ
    FEBS JOURNAL, 2005, 272 (14) : 3512 - 3520
  • [36] Alterations in Circulatory and Renal Angiotensin-Converting Enzyme and Angiotensin-Converting Enzyme 2 in Fetal Programmed Hypertension
    Shaltout, Hossam A.
    Figueroa, Jorge P.
    Rose, James C.
    Diz, Debra I.
    Chappell, Mark C.
    HYPERTENSION, 2009, 53 (02) : 404 - 408
  • [37] Endothelin-1 Downregulates Angiotensin-Converting Enzyme-2 Expression in Human Bronchial Epithelial Cells
    Zhang, Hongliang
    Li, Yamin
    Zeng, Yan
    Wu, Renrong
    Ou, Jianjun
    PHARMACOLOGY, 2013, 91 (5-6) : 297 - 304
  • [38] Angiotensin-converting enzyme 2 polymorphisms and cardiovascular risk
    Grace, J. A.
    Burrell, L. M.
    Patel, S. K.
    INTERNAL MEDICINE JOURNAL, 2012, 42 (10) : 1167 - 1167
  • [39] Angiotensin-converting enzyme-2 overexpression attenuates inflammation in rat model of chronic obstructive pulmonary disease
    Tian Xue
    Nie Wei
    Zhou Xin
    Xiu Qingyu
    INHALATION TOXICOLOGY, 2014, 26 (01) : 14 - 22
  • [40] Higher pharyngeal epithelial gene expression of angiotensin-converting Enzyme-2 in patients with upper respiratory infection
    Zhang, Mingjiao
    Du, Lingyan
    Faleti, Oluwasijibomi Damola
    Huang, Jing
    Xiao, Gang
    Lyu, Xiaoming
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2021, 103 : 378 - 380